These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 33909065)
21. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2. Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325 [TBL] [Abstract][Full Text] [Related]
22. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. Choudhury A; Mukherjee S J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269 [TBL] [Abstract][Full Text] [Related]
23. Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans. Robson B Comput Biol Med; 2020 Jul; 122():103849. PubMed ID: 32658736 [TBL] [Abstract][Full Text] [Related]
24. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides. Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962 [TBL] [Abstract][Full Text] [Related]
25. Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein. Li B; Wang L; Ge H; Zhang X; Ren P; Guo Y; Chen W; Li J; Zhu W; Chen W; Zhu L; Bai F Front Chem; 2021; 9():659764. PubMed ID: 34368076 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
27. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
28. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Zamorano Cuervo N; Grandvaux N Elife; 2020 Nov; 9():. PubMed ID: 33164751 [TBL] [Abstract][Full Text] [Related]
29. Two Receptor Binding Strategy of SARS-CoV-2 Is Mediated by Both the N-Terminal and Receptor-Binding Spike Domain. Monti M; Milanetti E; Frans MT; Miotto M; Di Rienzo L; Baranov MV; Gosti G; Somavarapu AK; Nagaraj M; Golbek TW; Rossing E; Moons SJ; Boltje TJ; van den Bogaart G; Weidner T; Otzen DE; Tartaglia GG; Ruocco G; Roeters SJ J Phys Chem B; 2024 Jan; 128(2):451-464. PubMed ID: 38190651 [TBL] [Abstract][Full Text] [Related]
30. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
31. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2. Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332 [TBL] [Abstract][Full Text] [Related]
32. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies. Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480 [TBL] [Abstract][Full Text] [Related]
33. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Scheim DE Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269703 [TBL] [Abstract][Full Text] [Related]
34. Integrin mediates cell entry of the SARS-CoV-2 virus independent of cellular receptor ACE2. Liu J; Lu F; Chen Y; Plow E; Qin J J Biol Chem; 2022 Mar; 298(3):101710. PubMed ID: 35150743 [TBL] [Abstract][Full Text] [Related]
35. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2. Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390 [TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 Li Z; Zhang JZH Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759 [TBL] [Abstract][Full Text] [Related]
37. Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells. Hattori T; Saito T; Okuya K; Takahashi Y; Miyamoto H; Kajihara M; Igarashi M; Takada A Microbiol Spectr; 2022 Aug; 10(4):e0087022. PubMed ID: 35862965 [TBL] [Abstract][Full Text] [Related]
38. ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility. Ma C; Gong C J Med Virol; 2021 Jul; 93(7):4469-4479. PubMed ID: 33755203 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. Hatmal MM; Alshaer W; Al-Hatamleh MAI; Hatmal M; Smadi O; Taha MO; Oweida AJ; Boer JC; Mohamud R; Plebanski M Cells; 2020 Dec; 9(12):. PubMed ID: 33302501 [TBL] [Abstract][Full Text] [Related]
40. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection. Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]